Research over the past three decades has shown that the mammalian immune system can be altered by the occupational exposure of asbestos. Early clinical studies generally focused on systemic observations of immune alteration such as the number and function of peripheral lymphocytes and monocytes. More recently as the regulatory influence of local immunity in health and disease becomes more defined, immunologic changes occurring in the lung, the primary target organ of asbestos, have been significant areas of investigation. This review will focus on recent studies that examine the influence of asbestos on pulmonary immunity as well as the role of host immune competence in asbestos-related disease. -Environ Health Perspect 106(Suppl 1):
Introduction
Occupational exposure to asbestos is widely believed to pose an increased risk for a range of pulmonary diseases and is considered an important cause of pulmonary cancer (i.e., diffuse malignant mesothelioma, bronchiogenic carcinoma). The predominant disease associated with asbestos exposure, asbestosis, is characterized by an interstitial pulmonary fibrosis commonly thought to represent the terminal phase of chronic inflammation (1, 2) . This inflammatory response, along with evidence of peripheral immune changes following asbestos exposure, has long implicated the pathogenesis of asbestos-related disease (3) .
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Fax: (303) . E-mail: grosenthal@aol.com Abbreviations used: AM, alveolar macrophage(s); DMTU, dimethylthiourea; FIGF, fibroblast inhibitory growth factor; IGF, insulinlike growth factor; IL, interleukin; MCP-1, macrophage chemotactic protein 1; MIP, macrophage inflammatory protein; NF, nuclear factor; NK, natural killer; PDGF, platelet-derived growth factor; PMN, polymorphonuclear neutrophil; ROS, reactive oxygen species; SCID, severe combined immunodeficiency disease; TGF-a, transforming growth factor alpha; Th, T-helper; TMTU, tetramethylthiourea; TNF, tumor necrosis factor; Ts, T-suppressor. Unlike many industrial immunotoxicants, for which relatively little clinical data are available, there exists a comparatively large literature database documenting the direct and indirect effects of asbestos on the human immune system, although the specific role of these changes in eliciting asbestos-related disease is unclear. In numerous clinical studies both humoral and cellular immunity have been targets of asbestos toxicity (4) (5) (6) (7) (8) (9) (10) (11) (12) . For example, studies performed in the late 1980s by researchers at the Mount Sinai School of Medicine, New York (4) used peripheral blood lymphocytes in their examination of T cells, T-cell subsets, and natural killer (NK) cells in 118 healthy control subjects and compared these data to those obtained from 20 patients with clinically diagnosed malignant mesothelioma and 375 long-term asbestos workers without neoplasia. These studies showed that whereas the absolute numbers of total T cells and T-helper (Th) cells were normal in asbestos workers without neoplasia, these cells were significantly reduced in patients with neoplasia. T-suppressor (Ts) cells, on the other hand, remained unchanged in the mesothelioma population but were significantly elevated among the asbestos workers without neoplasia. This imbalance in T-cell subsets resulted in a marked reduction in Th to Ts ratios in mesothelioma patients and in asbestos workers.
Similar to its effects on cellular immunity, a number of reports demonstrate asbestos-associated changes in humoral immunity, as manifested by increased circulating levels of immunoglobulins (6) , including auto-antibodies and rheumatoid factors (8, (10) (11) (12) . More recently, studies have experimentally demonstrated the importance of certain components of the complement system (13, 14) and the importance of fiber deposition and interstitial translocation to the ultimate pathology associated with asbestos-related inflammation. Specifically, following transepithelial passage, fiberinduced activation of local complement can generate potent chemoattractants that likely serve as important initiators of inflammatory events (13, 14) . These studies were recently reviewed by Warheit and Hesterberg (15) . The purpose of this paper is to summarize recent key developments in our understanding of the complex interactions of asbestos with cells of the immune system.
Influence ofAsbestos Exposure on Nonspecific Inmmunity: Natural Killer Cells Natural killer cells are a unique lymphocyte population with the ability to rapidly lyse tumor cells independent of major histocompatibility complex gene products (16) and are thought to be the first line of defense against cancer cells or virally infected cells (17, 18) .
In addition to the ability of asbestos fibers to substantially increase the risk of pulmonary malignancy, clinical studies have shown that NK cells isolated from peripheral blood of patients with asbestosis have impaired NK cell activity, thus leading to speculation that such suppression may have a causative or multiplicative effect on the risk for lung cancer in these individuals (4, 5 (20) .
In light of the previously reported observations of decreased number and function of circulating NK cells in asbestosexposed workers, studies were conducted to examine the influence of inhaled asbestos on interstitial NK number and function in C57BL/6 mice (21) . In these studies C57BL/6 mice were exposed to chrysotile asbestos (-13.3 mg/m3) for 3 hr/day for 3 days and animals sacrificed at 7, 28, and 56 days postexposure. Functional assessment of the interstitial NK population was determined by evaluation of their ability to lyse target YAC-1 cells. As in Table 1 , the ability of pulmonary NK cells to lyse target cells was significantly suppressed in asbestosexposed mice on days 7 and 56 postexposure compared to air-exposed animals. Although cytotoxicity appears decreased in asbestosexposed animals on day 28, the degree of suppression did not reach statistical significance. This suppression in target cell-mediated cytotoxicity by NK cells isolated from asbestos-exposed mice correlated to some extent with the percentages of NK cells recovered from these mice, which were below those recovered from air controls at all time points examined ( Table 2 ). The effect of asbestos on pulmonary NK cells appears relatively specific, as the relative and absolute numbers of pulmonary T cells ( (4, 5) , the number of local or interstitial NK cells in pulmonary tissue may also be altered following exposure to asbestos. Further studies will be necessary to understand the importance of this altered cellular distribution in local immune regulation as well as in the pathogenesis of asbestos-related disease. (13, 14) . The role of the other locally produced factors such as monocyte chemotactic protein 1 (MCP-1) and macrophage inflammatory protein (MIP)-1a and -1i, known chemoattractants for monocytes (27) , is not yet well characterized for the asbestos-induced inflammatory response. In addition, the proliferative response of the AM population seen after silica and asbestos exposure may be induced by colony-stimulating factors (28) and is believed to be associated with the formation of multinucleated giant cells (29) , a prominent feature in the chronic stage of asbestosis and silicosis (30, 31) . In addition, AM produce insulinlike growth factor (IGF)-1 and express its receptor, thus creating an environment for the autocrine stimulation ofAM proliferation (32, 33) . AM provide dual defense of the lower respiratory tract, induding phagocytosis and removal of inhaled fibers and triggering local immunologic events that may be protective. As a phagocytic cell the AM helps clear the lung of inhaled particles. Evaluation of AM from humans and animals exposed to high concentrations of asbestos show phagocytized fibers in numerous AM (24) . Several lines of in vitro evidence suggest that AM, unlike the polymorphonudear neutrophil(s) (PMN), which also increase in asbestosis, can reduce asbestos-induced epithelial cell injury through initiation of key repair processes (34, 35) .
Activated AM are abundant sources of proinflammatory mediators and growth factors with important roles in the pathogenesis of inflammatory and fibrotic processes in the lung. The oxygen meta-bolites and eicosanoids released from AM during the phagocytosis of asbestos fibers are well documented (24, 36, 37) . Overwhelming evidence shows that the pulmonary macrophage can be stimulated by asbestos to express and secrete multiple inflammatory cytokines, chemokines, and growth factors participating in both auto-crine and paracrine stimulation of resident lung cells and blood cells (Table 4) . Tumor necrosis factor (TNF) alpha has received considerable attention in this regard, as several lines of evidence suggest that it plays a significant role in fiberinduced lung disease. AM secrete TNF-a after in vivo inhalation, in vitro exposure to asbestos fibers (38) (39) (40) , and AM from asbestosis patients (41) or patients with history of chronic asbestos exposure (38) demonstrate an increase in TNF-a message expression and secretion. Additionally, excess TNF-a correlates with development of fibrosis in animal models of asbestosis (42, 43) . Interestingly, the long fibers, which are generally considered more carcinogenic and fibrogenic than short fibers of similar diameter (44), stimulated a greater release of TNF-a than the short samples (45). TNF-a administrated in vivo can elicit many of the responses associated with asbestosis, including proliferation of fibroblasts (46,47), stimulation of extracellular matrix proteins (41), and elicitation of inflammatory cells via enhanced adhesion molecule expression and the production of chemokines (48) . Consistent with a role for TNF in particulate-related lung disease, studies have shown that the administration of antibodies to TNF-a prevents collagen deposition induced by silica, another fibrogenic material (49) .
In light of their propensity to elicit potent inflammatory cytokines, it is not surprising that AM are thought to be involved in the recruitment of neutrophils to the lung. AM from subjects with asbestosis release neutrophil chemotactic factors (50) , which may be a secondary response to TNF-a and directly stimulated by asbestos itself. The presence of neutrophils is a frequent finding in animal models of asbestosis (22) and humans occupationally exposed to asbestos (51, 52) . Elevated neutrophils are often associated with lung damage, as they are potent producers of reactive oxygen and proteolytic enzymes, both with the potential to destroy respiratory tissue. Human interleukin (IL)-8 and its mouse analog MIP-2, chemokines from the a-intecrine family, are the most stable and potent chemotactic factors for PMN in the lung (53) . Further evidence for fiber-induced induction of inflammatory cytokines can be seen in recent studies showing that silica induces MIP-2 from AM (54) and asbestos stimulates IL-8 production from lung epithelial cells (55) and human AM (56) . (7, 8, 9) . The incidence of autoantibodies in asbestos-exposed workers with radiographic abnormalities varies widely and ranges from 3 to 28% for antinuclear antibody and from 10 to 38% for rheumatoid factor (7, 8, 10, 12, 74) . Although elevated levels of IgG and IgM appear to correlate with chest radiographic classification of pneumoconiosis, no correlation exists between autoantibody production or serum immunocomplexes and the severity of asbestosis (9 (77) . Alternatively, it has been suggested that asbestos-induced B-cell overactivity may be related to decreased suppressor cell activity and/or numbers previously reported in asbestos-exposed workers. Although the effects of asbestos on humoral immunity can be considered hyperactive, the clinical studies to date portray a significantly depressed cell-mediated immune response in asbestos-exposed individuals. A clear relationship between defective T-cell functions and the fibrotic response in asbestosis has been demonstrated (7, 78, 79) , with the intensity of the decrease paralleling the severity of the disease (79) . Asbestos-exposed patients with impaired T-cell responses have more severe fibrotic abnormalities (as determined by chest radiography) than those with normal responses, and patients with increases in bronchoalveolar lymphocytes present with less physiologic impairment than those with increased neutrophils and eosinophils (78, (80) (81) (82) . Furthermore, the unexpected longevity of a patient with malignant pleural mesothelioma was associated with normal lymphocyte surface markers and functions in contrast to mesothelioma patients who terminally progressed with suppressed numbers and function of T and B lymphocytes (83) . However, in one study no association was found between impaired cellular immunity and asbestos-associated malignancy in eight of ten patients with asbestos-associated pleural mesothelioma and without lung fibrosis (78) , indicating that impaired T-cell function is an unlikely finding in all asbestos-associated malignancy. In patients with radiographic evidence of parenchymal asbestosis, both the relative and absolute number of circulating T lymphocytes were significantly depressed compared to control (7) . This T-cell deficit was associated with suppressed mitogeninduced lymphocyte proliferation, cutaneous anergy to dinitrochlorobenzene, and depressed delayed-type hypersensitivity to several antigens (7, (84) (85) (86) . In vitro studies with human peripheral blood lymphocytes have shown that asbestos-depressed phytohemoagglutinin A induced lymphoproliferation in a manner that was only partially related to cytotoxicity (87, 88) . Reduced CD4:CD8 ratios in bronchoalveolar lavage fluid have been described in asbestosexposed workers with and without radiologic evidence of asbestosis; this finding has correlated with pleural thickening (89) (90) (91) . A local excess of Ts cells or depletion of Th cells might result from nonspecific activation of the immune system secondary to AM activation by asbestos. Although unlikely, reduced CD4:CD8 ratios may result from nonspecific direct damage to lymphocytes by asbestos fibers. It is conceivable that the loss of Ts cell regulation could explain the B-cell reactivity and that the neoplastic cell-transforming properties of asbestos might act in concert with this immune-deficient host. In addition one may speculate that the previously described effects on NK cells may be related to the observation that among asbestos-exposed workers with depressed T-cell functions there is an increase in the number of the effector Ts (Leu2+ Leu8-) subsets that regulate both the Th:Ts ratio as well as B-and NK cell activity (92) .
Although T cells are clearly a target of asbestos exposure, it is important to note that asbestos-exposed individuals present myriad patterns of T-cell subset alterations, including an increased CD4:CD8 ratio (93) . Interestingly, chrysotile asbestos interferes with phytohemaglutin or concanavalin A-induced release of fibroblast inhibitory growth factor (FIGF) from peripheral blood lymphocytes in vitro (94) . Thus, while FIGF may regulate the extent of connective tissue proliferation during normal repair process, suppression of it by asbestos may contribute to excessive fibroblast accumulation and subsequent fibrosis.
Although most immunologic alterations are generally found in patients with radiologic evidence of asbestosis, two studies have reported leukopenia in presumably healthy individuals with occupational asbestos exposure (95, 96) . Thus, it is difficult to establish whether the cellular defects precede or are the consequences of the development of fibrosis. To answer this question, our laboratory evaluated asbestosinduced inflammatory and fibrotic responses in lungs of immunodeficient mice (Balb/c nu/nu) and severe combined immunodeficient (SCID) (C3H) mice, immunologically normal mice of the same genetic background, and immunodeficient mice reconstituted with syngeneic T lymphocytes (97) . In these studies, increases in bronchoalveolar lavage cell numbers occurred in asbestos-treated immunodeficient mice compared to asbestos-treated immunocompetent mice or immunodeficient mice that were reconstituted with crude and purified T lymphocytes (Table 6 ). Differential analysis of the collected cells portrayed a predominantly neutrophilic infiltrate, which correlated with increased levels of LTB4 and PGE2. Both asbestos-treated athymic and SCID mice showed a significant increase in total lung hydroxyproline when compared to asbestostreated immunocompetent mice (Table 7) . Consistent with this, lung hydroxyproline was reduced in asbestos-exposed SCID mice reconstituted with T lymphocytes and conversely increased in T-cell depleted Balb/c mice (data not shown). Histopathologic assessment demonstrated that asbestos exposure was associated with both cellular and fibrogenic inflammatory responses, with asbestos-exposed SCID mice presenting with a more severe cellular response than similarly exposed normal mice (Table 8) . Taken together, these data indicate that T cells influence asbestosinduced lung damage by minimizing both the inflammatory and fibrotic responses and taken together are consistent with a protective role for T lymphocytes in asbestosis. It is likely that the more severe neutrophil infiltration and the greater retention time of these cells in the lung of immunodeficient mice causes more extensive lung injury. Op<0 .05 compared to airexposed C3H or air-exposed SCID mice. *p<0.05 significantly different versus asbestos-exposed SCID mice. Table adapted &Number of mice affected/number evaluated. hSeverity of collagen deposition was based on evaluation of a single Trichrome-stained section from each animal. All slides were evaluated initially to determine the maximal extent of the lesion then reevaluated and semiquantitatively graded on a scale of +1 (minimal) to +3
(maximal). This grading was based on the number of inflammatory foci in the section that contained increased collagen, as well as the amount of collagen present in individual foci. Combined experiments are shown. (108, 109) . In this respect asbestos bodies removed from human lung at autopsy have contained on their surface redox-active iron capable of catalyzing DNA single-strand breaks (110) . An additional mechanism for the induction of oxidative stress by asbestos is through the activation of macrophages and polymorphonuclear leukocytes to release ROS in the form of H202 and 02- (111) . In iron-catalyzed reactions these metabolites can be converted to hydroxyl radicals. Incomplete internalization of long asbestos fibers, so-called frustrated phagocytosis (112) , or the specific stimulation of oxidant-producing enzymes such as reduced nicotinamide adenine dinucleotide phosphate oxidase (113) (120) . A number of studies evaluating the role of iron and the production of ROS in asbestos toxicity utilize the potent iron chelator desferrioxamine. For example, treatment of asbestos fibers with desferrioxamine effectively chelates ferric ions from the fiber surface, decreases the ability of asbestos to generate OH radicals (100) , and decreases the ability to induce cell toxicity (121), lipid peroxidation (122, 123) , and DNA damage (124) . Pretreatment of asbestos fibers with desferrioxamine or treatment of AM with asbestos in the presence of desferrioxamine markedly diminishes the ability of the fibers to stimulate TNF-a production (Figure 4) . Similar inhibition of an asbestos-induced TNF-ct response was demonstrated by membrane-permeable hydroxyl scavengers such as dimethylthiourea (DMTU), tetramethylthiourea (TMTU), and dimethyl sulfoxide. Additionally, TNF-ax secretion from AM is stimulated by H202 or glucose-glucose oxidase, generating H202; this response is increased in the presence of ferrous sulfate, which catalyzes hydroxyl radical generation through Fenton reaction. Asbestos-induced oxidative stress is also involved in the stimulation of cytokine responses from pulmonary epithelial cells (125, 126) . Membrane-permeable hydroxyl scavengers significantly attenuate asbestosactivated IL-8 and IL-6 gene expression in pulmonary epithelial cells. Free radical generating systems induce IL-8 and IL-6 secretion similar to asbestos. Using antioxidants, transient transfection assays using an IL-8 promoter construct linked to a Chloramphenicol acetyltransferase reporter gene revealed that asbestos-mediated redox-oxidative intracellular changes are involved in the IL-8 promoter activation ( Figure 5 ).
Cytokine gene transcription and expression are generally associated with the modulation of gene promoter regions by sequence-specific binding of proteins, referred to as transcription factors. Nuclear factor (NF)-KB is a transcription factor controlling the gene expression of many inflammatory cytokines including TNF-a, IL-la, IL-8, and IL-6 (127) (128) (129) . There is increasing evidence that the redox-oxidative stage of the cell can play a role in NF-cKB activation (130, 131) . ROS 
Conclusion
Asbestos has proven to be an important immunotoxicant with effects on both systemic and local immunity. In fact few, if any, immunologic cells appear to be spared by asbestos exposure, either through direct effects or as a result of the hosts' protective response to exposure. Although recent studies have begun to shed light on the cellular and subcellular events responsible for asbestos-related immune dysfunction, these same studies have also shown the remarkable complexity in fiber-cell and cell-cell interactions involved in asbestosrelated disease processes. However, key questions remain to be fully understood, including an understanding of the genetic predisposition of individuals with a tendency for immunologic hyperactivity to asbestos, the interactions between systemic and local immune changes, and the influence of complex mixtures of cytokines/growth factors on the pathogenesis of asbestos-induced lung disease Nevertheless, the impressive data generated to date on asbestos-immune system interactions will likely aid in identifying the toxic and neoplastic properties of additional natural and synthetic fibers. 43 . Lemaire 
